Enhanced overall and progression-free survival in advanced melanoma patients undergoing targeted therapy alongside antithrombotic treatment – Insights from a multicenter study involving 1296 patients from the prospective skin cancer registry ADOReg
Concomitant AC, particularly factor Xa-inhibiting direct oral anticoagulants, was associated with improved survival in melanoma patients undergoing TT. These findings support prospective trials evaluating AC as concomitant therapy in advanced melanoma.
Institutions
- Universität Hamburg (DE)
- Bielefeld University (DE)
- Hochschule Bielefeld (DE)
- Heidelberg University (DE)
- Skin Cancer Foundation (US)
- University Medical Center Freiburg (DE)
- University Hospital Heidelberg (DE)
- University Hospital Regensburg (DE)
- Düsseldorf University Hospital (DE)
- SRH Wald-Klinikum Gera (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- University Hospital Schleswig-Holstein (DE)
- Essen University Hospital (DE)
- University Cancer Center Hamburg (DE)
- Elbe Kliniken Stade-Buxtehude (DE)
- Helios Klinikum Erfurt (DE)
- Comprehensive Cancer Center Erlangen (DE)
- University Medical Centre Mannheim (DE)
- West German Heart and Vascular Center Essen (DE)
- University Hospital Carl Gustav Carus (DE)
- Johannes Wesling Klinikum Minden (DE)
- Heinrich Heine University Düsseldorf (DE)
- University of Duisburg-Essen (DE)
- University of Tübingen (DE)
- Saarland University (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- European Journal of Cancer
- Published
- 2025-12-19
- DOI
- https://doi.org/10.1016/j.ejca.2025.116195
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00